HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers.

Li, Bob T

HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers. [electronic resource] - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Mar 2016 - 414-9 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1556-1380

10.1016/j.jtho.2015.10.025 doi


Adenocarcinoma--enzymology
Adenocarcinoma of Lung
Aged
Female
Gene Amplification
Genes, erbB-2
Humans
In Situ Hybridization, Fluorescence
Lung Neoplasms--enzymology
Male
Middle Aged
Molecular Targeted Therapy
Mutation
Receptor, ErbB-2--genetics